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Background: The search for a reliable, valid and cost-effective comorbidity risk adjustment method for outcomes
research continues to be a challenge. The most widely used tool, the Charlson Comorbidity Index (CCI) is limited
due to frequent missing data in medical records and administrative data. Patient self-report data has the potential
to be more complete but has not been widely used. The purpose of this study was to evaluate the performance of
the Self-Administered Comorbidity Questionnaire (SCQ) to predict functional capacity, quality of life (QOL) health
outcomes compared to CCI medical records data.
Method: An SCQ-score was generated from patient interview, and the CCI score was generated by medical record
review for 525 patients hospitalized for Acute Coronary Syndrome (ACS) at baseline, three months and eight
months post-discharge. Linear regression models assessed the extent to which there were differences in the ability
of comorbidity measures to predict functional capacity (Activity Status Index [ASI] scores) and quality of life
(EuroQOL 5D [EQ5D] scores).
Results: The CCI (R2 = 0.245; p = 0.132) did not predict quality of life scores while the SCQ self-report method
(R2 = 0.265; p < 0.0005) predicted the EQ5D scores. However, the CCI was almost as good as the SCQ for predicting
the ASI scores at three and six months and performed slightly better in predicting ASI at eight-month follow up
(R2 = 0.370; p < 0.0005 vs. R2 = 0.358; p < 0.0005) respectively. Only age, gender, family income and Center for
Epidemiologic Studies-Depression (CESD) scores showed significant association with both measures in predicting
QOL and functional capacity.
Conclusions: Although our model R-squares were fairly low, these results show that the self-report SCQ index is a
good alternative method to predict QOL health outcomes when compared to a CCI medical record score. Both
measures predicted physical functioning similarly. This suggests that patient self-reported comorbidity data can be
used for predicting physical functional capacity and QOL and can serve as a reliable risk adjustment measure.
Self-report comorbidity data may provide a cost-effective alternative method for risk adjustment in clinical research,
health policy and organizational improvement analyses.
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Comorbidity is an important independent predictor of
in-hospital mortality and is routinely used in risk adjust-
ment. [1-4] The influence of comorbidity on patient
outcomes such as quality of life and functional status
is less well known. [4-7] As part of a larger study of
chronic disease self-management over eight months
post-hospitalization for acute coronary syndrome (ACS),
we sought to evaluate a self report comorbidity measure
that would minimize the need to access medical records
while maintaining predictive validity as reflected in the
association with functional capacity and quality of life.
Evaluating interventions in patient populations with
chronic conditions frequently requires attention to co-
morbidity risk adjustment when examining global out-
come measures such as functional capacity, health status
and emotional well-being [2].
Although several comorbidity measures have been
developed [6-9] the Charlson Comorbidity Index (CCI)
derived from medical record data remains the most
widely used risk adjustment tool. [10,11] Charlson et al
[10] initially used multivariate analysis to develop a
weighted comorbidity index designed to predict one-
year mortality. This index was initially tested on a sam-
ple of medical hospital inpatients and later validated on
a test population of breast cancer patients at another
acute care facility. [10] The CCI has also been adapted
for use with administrative data as a predictor of morta-
lity, length of stay, resource utilization, and treatment
complications [12].
Comorbidity information from either medical records
or administrative data sources can be limited by a)
quality of documentation, [13,14] b) limited availability
of recent documentation, and c) under-reporting of pre-
admission conditions judged by clinicians to be less per-
tinent to patients’ admitting diagnoses [15-17]. Medical
record notes may also frequently contain elements of
both patient self-report and earlier professional documen-
tation, sometimes offering a hybrid source of original data
[15,16,18].
These limitations have led to increased interest in
using patient self-report to calculate composite comor-
bidity levels [14,17,19-21]. Research has shown that
many patients can accurately report their current
[17,21-23] and past medical conditions, [24-26] inclu-
ding comorbidities. [14,21,27] However, data are limited
regarding how well a self-report comorbidity score pre-
dicts functional capacity or quality of life health out-
comes [4].
The few global self-report comorbidity measures have
been far less widely used and validated than administra-
tive or medical record derived measures. While self-
report measures are subject to missing data due to in-
complete filling of forms, the main challenge with anyself-report measure is to translate medical language to
plain language that patients can understand without as-
sistance from a health professional. The most frequently
used measure was developed by Katz et al [14]. The
Self-Administered Comorbidity Questionnaire (SCQ)
was designed to be an equivalent self-report analog of
the Charlson Index. Silliman et al [28] designed a “quasi”
self-report study using time to death as the outcome of
interest but only used the SCQ measure with only 303
breast cancer patients. Other self-report measures are
generally disease specific rather than general measures.
The SCQ was therefore chosen for the present analyses
since it contains the same elements as the CCI and has
demonstrated adequate face validity due to its careful
development.
The objective of this study was to evaluate the per-
formance of the SCQ to predict functional capacity,
quality of life health outcomes compared to CCI medical
records data in the same patients, admitted to hospital
with a diagnosis of ACS.
Methods
Sample
Medical record data were collected from a sample of
719 ACS patients hospitalized in five mid-Michigan
hospitals as part of a trial of a telephone intervention
program. The intervention was designed to improve
patients’ health behaviors within a post-discharge quality
improvement program. [29] For detailed information,
see Holmes-Rovner et al [29].
Data concerning patients’ socio-demographic charac-
teristics, comorbid conditions, and subsequent func-
tional capacity and quality of life were collected from: 1)
medical record chart abstractions at baseline, as well as
2) structured panel telephone patient interviews con-
cerning patients’ functional capacity and quality of life at
approximately three and eight months after discharge.
All medical records data were collected by a group of
nurse chart abstractors who were trained by the study
Community Project Manager (CPM). Each chart abstractor
used a standard data collection sheet and made reference
to a chart abstraction manual concerning specific data field
definitions and parameters.
Telephone interviews of post-discharge patient health
outcomes were conducted by trained survey researchers at
the authors’ university-based survey institute at three time
periods: 1) at baseline shortly after index hospitalization
(Mean = 14.11 days, SD = 9.6), 2) at three months, and 3)
eight months after index hospitalization. The study was
approved by Michigan State University Biomedical, Health
Sciences IRB.
Of 719 consenting subjects, 525 (73.0%) patients com-
pleted a baseline interview and had complete data con-
cerning their personal characteristics and comorbid
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total of 440 (83.9% of baseline interviewed) completed a
three-month interview, and 388 (88.2% of three-month
interviewed) completed an eight-month interview.
Including attrition from initial consent, 72.5% completed
a baseline interview, with further panel attrition of
16.6% and 11.8% at three and eight months, respectively.
Before any data were collected, approval had been
obtained from the authors’ institutional review board
and each participating hospital. In order to ensure
largely complete information, we reduced the effective
analytic sample sizes to 525 (baseline), 438 (3-month)
and 387 (8-month).
Study measures
Patients’ socio-demographic characteristics included: race
(White and Non-White), marital status category (married
and divorced/separated/widowed), education completed
(less than high school and high school or greater), and
family income level category (< $15,000 per year, and
$15,000 or more per year). Patient age (in complete years)
was treated as a continuous variable.
Depressive symptoms were measured using the Center
for Epidemiologic Studies-Depression Scale (CESD). [30]
The CESD [30] is a validated 20-item self-report screening
instrument designed to measure the frequency/duration
of depressive symptoms in non-psychiatric community
populations. A composite CESD score of 16 or greater is
correlated with a mild to moderate level of depressive
symptoms and was used as a cut-point in our study
[30-32]. The instrument has demonstrated adequate in-
ternal consistency (α = .85 to .95) in general, psychiatric,
and medical populations [30].
Medical records were used to generate the CCI com-
posite comorbidity scores [10,11]. The CCI has been
tested with large samples in numerous settings. [1,6,
7,33] With this index, a patient’s composite CCI score is
calculated as a weighted sum of the presence of 19 do-
cumented health conditions such as Congestive Heart
Failure, Diabetes, or Peripheral Vascular Disease. For
our analyses, we used the original Charlson weightingTable 1 Comparison of contributions of Katz (Self-Report) and
ASI (Functional-Capacity) scores
Outcome: 3-Month ASI (N=438) Model R-Squared R-squared C
Model with covariates onlya 0.317 0.317
Covariate model +Katz 0.340 0.023
Covariate Model + Charlson 0.331 0.014
Outcome: 8-Month ASI (N=387) Model R-Squared R-squared C
Model with covariates onlya 0.334 0.334
Covariate model +Katz 0.358 0.025
Covariate Model + Charlson 0.370 0.036
a. covariates: age, gender, race, education, household income, marital status, deprescheme assigning a score of 1, 2, 3, or 6 to each
appropriate comorbidity condition and summing these
values.
The Katz Self-Administered Comorbidity Question-
naire (SCQ) was used in its full 19 item version. [14]
The SCQ includes items corresponding to each of those
in the CCI [10,11]. The individual item weightings for
the Katz SCQ [14] method are almost entirely the same
as for the CCI. [10,11] In the original Katz et al study,
test-retest reliability, assessed with the intra-class corre-
lation coefficient, was 0.91 for the questionnaire and
0.92 for the CCI. The Spearman correlation between
these two measures was 0.63. [14] Subsequent develop-
ment of the measure has reduced the number of items
to thirteen [17].
The outcome measures used in these analyses included
the five-item EuroQOL 5D scale, a commonly used
Quality of Life measure that combines patient responses
at each of the three panel interviews to questions about
five quality of life dimensions. [34] These dimensions
include Mobility, Self-Care, Usual Activities, Pain/
Discomfort, and Anxiety/Depression, with the respon-
dent indicating whether each of these dimensions were
frequently, occasionally, or never, a problem in their
daily lives.
Functional capacity was measured using the Activity
Status Index (ASI). [35] The ASI is a 12-item measure
of a person’s physical functional capacity that was deve-
loped to correlate with peak oxygen uptake, a criterion
particularly relevant to the functional status of cardiac
patients. The ASI has been found to have adequate
sensitivity to clinical changes and to be moderately
(r = 0.58) correlated with other measures of cardiovas-
cular fitness such as measures of peak oxygen intake
during exercise testing. [35] Scale scores can range from
0 to 58.2 with higher scores indicating better functional
capacity [35].
Information on overall level of cardiac functioning of
the ACS patients was included in predictive models,
using cardiac ejection fraction, a continuous measure
with a possible range of 0% or 100% [36].Charlson (Medical-Record) comorbidity information to








ssive symptomatology (CESD), ejection fraction, invasive cardiac procedures.
Table 2 Comparison of contributions of Katz (Self-Report) and Charlson (Medical-Record) comorbidity information to
EQD-5 (Quality-of-Life) scores
Outcome: 3-Month EQD-5 (N=438) Model R-Squared R-squared Change F-Test/ F-change Degrees of freedom P-value
Model with covariates onlya 0.259 0.259 10.56 14/423 <0.0005
Covariate model +Katz 0.288 0.029 17.27 1/422 <0.0005
Covariate Model + Charlson 0.262 0.003 1.64 1/422 >0.201
Outcome: 8-Month EQD-5 (N=387) Model R-Squared R-squared Change F-Test/ F-change Degrees of freedom P-value
Model with covariates onlya 0.240 0.240 8.40 14/372 <0.0005
Covariate model +Katz 0.265 0.025 12.52 1/371 <0.0005
Covariate Model + Charlson 0.245 0.005 2.28 1/371 >0.132
a. covariates: age, gender, race, education, household income, marital status, depressive symptomatology (CESD), ejection fraction, invasive cardiac procedures.
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Sample descriptive statistics, including frequencies, percen-
tages, means and standard deviations were calculated to
summarize the socio-demographic and health status char-
acteristics of the patients. Mean scores for the EQ5D and
the ASI were calculated for the analytic samples including
(1) all cases with available information, and (2) the subset
with complete information at all three interview times, to
gauge the effects of attrition on mean changes over time.Table 3 Demographic & clinical characteristics of patients
at baseline (n = 525)
Variable N







Current Marital Status 525
Married 350 (66.7%)
Divorced/Separated/Widowed 174 (33.1%)




Less than High School 99 (18.9%)
High school diploma or higher 426 (81.8%)
Family Income 467
Less than $15,000 per year 113 (25.0%)
$15,000 or more per year 354 (75.8%)
Activity Status Index26 (scale 0 - 54.55) 525 M=29.56 (SD 17.21)
CESD Depression27 (scale 0 - 60) 524 M=13.56 (SD 10.48)
EuroQol 5D See Table 4
Ejection Fraction 452 M= 50.19 (SD 12.93 )To assess the extent to which there are differences in
the ability of the survey-based SCQ [14] and the
medical-record-based CCI [10] to predict physical func-
tional capacity (ASI scores) [35] and quality of life
(EQ5D scores) [34], linear regression models were used
two times: with 3-month, and 8-month ASI and EQ5D
outcomes. The initial full models with either ASI scores
or EQ5D scores as outcome variables include the follow-
ing set of covariates/predictor variables: time of inter-
view, age at MI, education, income, gender, race, marital
status, depression, ejection fraction at hospitalization,
and performance of interventions [percutaneous coron-
ary intervention (PCI) and coronary artery bypass graft
(CABG)].
In addition, these models were run twice, either
including the SCQ or CCI as independent predictors. A
backward stepwise regression approach was employed to
eliminate all independent variables, for which the incre-
mental F-test was not significant (p > 0.05) in both mo-
dels. Comparison of contributions of SCQ and CCI
comorbidity information to ASI scores (Table 1) and
EQD-5 scores (Table 2) at 3-months and 8-months post-
discharge were determined. All data analysis was carried
out using the Stata 10.1 software [37].
Results
The patient sample was typical of patients hospitalized
for ACS (See Table 3).
Changes of EQ5D and ASI over time are shown in
Table 4. Results showed no changes in the mean quality of
life (EQ5D) scores (F = 0.79, p < 0.455) and a decrement
in functional capacity (ASI) from pre-hospitalization to
three months after hospital discharge, with a small reco-
very between the 2nd and 3rd interview five months later
(F = 8.22, p < 0.001).
Results from the linear regression models comparing
the contributions of SCQ and CCI comorbidity informa-
tion to ASI scores and EQ5D scores at 3-month and
8-month after hospitalization are shown in Tables 1 and 2.
Results revealed that both the SCQ and CCI predicted
ASI (functional capacity) at 3-months and 8-months
Table 4 Mean EQ5D (Quality of Life) and ASI (Physical Functioning) scores over time
(A) EQ5D:
Time: EQ5D EQ5D
(including all cases) (completers of all interviews)
Mean St. Dev. N Mean St. Dev. N
Baseline Interview 0.749 0.262 515 0.760 0.257 381
3-month Interview 0.753 0.271 439 0.768 0.259 387




(including all cases) (completers of all interviews)
Mean St. Dev. N Mean St. Dev. N
Baseline Interview 29.55 17.20 525 30.46 16.78 388
3-month Interview 25.04 17.15 439 25.56 17.01 387
8-month Interview 26.87 17.74 388 26.87 17.74 388
F=0.8.22, p<0.001
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slightly better at 3-months (R2 = 0.340; p < 0.0005 vs.
R2 = 0.331; p < 0.0035) compared to the CCI. However,
the CCI predicted slightly better at the 8-month (R2 =
0.370; p < 0.0005 vs. R2 = 0.358; p < 0.0005) follow up
(See Table 1). It is important to note that the CCI did
not predict the quality of life (EQD5 scores) at 3-months
(R2 = 0.262; p > 0.201), or at 8-months (R2 = 0.245; p >
0.132) follow-up after ACS. However, the self-report
SCQ significantly predicted the EQD5 scores at
3-months (R2 = 0.288; p < 0.0005) and 8-months
(R2 = 0.265; p < 0.0005) follow up (see Table 2). CESD
was associated with EQ5D in all analyses with ASI
scores as the dependent variable in the regression model
with the SCQ measure included, after adjusting for all
socio-demographic and other covariates, ASI scores
decline steeply after hospitalization (-2.14, p = 0.000)
but did not differ significantly between three-months
and eight months, suggesting early and stable recovery
in functional capacity. Figure 1 graphically depicts these
comparative relationships for the two comorbidity mea-
sures on both ASI and EQ5D at baseline (lightest lines
at bottom) as well at three and eight months after hos-
pital discharge.
Covariates including race, education, marital status,
ejection fraction category, and invasive procedure were
consistently non-significant influences on both study
outcomes when including either SCQ or CCI comorbid-
ity measures. Several sample subgroups including those
with higher age, females, and subjects with lower family
income levels reported significantly lower levels of func-
tional capacity and quality of life during panel interviewswhen these terms were included in models with both
comorbidity methods.
In summary, the SCQ self-report method was an over-
all equivalent predictor of both the post hospitalization
EQ5D (quality of life) and the ASI (functional capacity)
scores compared to the CCI. For both regression
models, the incremental and overall R-squared values,
albeit fairly low, were slightly higher with the inclusion
of the SCQ as predictor instead of the CCI. Similar to at
least two earlier studies, [38,39] our fairly low R-squared
values may represent the many factors likely impacting
the functional capacity and quality of life outcomes for
such patients after an acute ACS hospitalization.
Discussion
In comparing performance of the SCQ and CCI, we
found the CCI did not predict the quality of life EQD5
scores after ACS. The CCI was not significantly asso-
ciated with the EQ5D scores at three months and at
eight months after hospitalization for ACS. The SCQ,
however, more significantly predicted the EQD5 scores
at three-months, and at eight months follow-up. How-
ever, CCI is almost as predictive as the SCQ for ASI
functional capacity scores at three and eight months,
and performing more significantly in predicting quality
of life at eight-month follow-up.
Our findings are particularly important because our
follow-up period allowed longer post-discharge assess-
ment of functional capacity and quality of life at inter-
vals longer than 30-day mortality, as is most often the
case when administrative data are used [9,40,41]. As we
reported previously, patients reported more of certain
Figure 1 Comparison of Three and Eight-Month CCI and SQC Scores on ASI & EuroQOL Outcomes. ASI = Activity Status Index,
Euroqol = EuroQol5d.
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with the medical record [42].
Our results indicate that having additional co-morbi-
dities, as self-reported by patients are relatively strong
predictors of quality of life (EQ5D scores); and func-
tional capacity (ASI scores). On average, our analysis
revealed that they decline by -0.02 (p < 0.001); and -2.00
(p< 0.001) for each unit increase in the self reports CCI
(Katz scores) for the EQ5D and ASI respectively. Simi-
larly, Motl et al [23] found statistically significant inverse
associations between the number of self-reported cardio-
vascular comorbidities and objectively measured and
self-reported physical activity. Their study revealed that
physical activity levels in persons with muscular sclerosis
were associated with the number of self-reported cardio-
vascular comorbidities, independent of disability status,and other possible cofounding influences. In another
smaller study, Bayliss et al [2] found that for certain
quality of life assessments, self-reported comorbidity
data may provide a more accurate estimate of comorbid-
ity than existing medical record reporting sources.
Susser et al [19] compared the predictive validity of self
report and administrative CCI using subsequent health
services utilization rates and functional decline as out-
comes. In contrast to our finding, they found that agree-
ment between self-report and administrative comorbidity
data was only poor to fair but both have comparative
levels of predictive validity.
Our study also found that higher depressive symptom
levels (CESD scores; -0.011, p < 0.001; -0.411, p < 0.001)
were significantly associated with both patients’ quality of
life and functional capacity. More depressed patients in
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and functional capacity after a hospitalization for ACS.
In our multivariate models, certain factors such as age,
gender, family income and CESD were significantly asso-
ciated with the Charlson CCI and self report SCQ in
predicting functional capacity. The self-report comorbidity
measure more significantly predicted QOL during the
eight-month study window.
Male ACS patients generally demonstrated higher QOL
and functional capacity levels after discharge. In addition,
patients with higher family incomes (> $40,000) did seem
to experience both a higher quality of life and level of
functional capacity. For future studies, these patterns
suggest that research interventions and analyses will need
to be effectively targeted to capture differential influences
of these factors on many health outcomes.
Katz and colleagues have continued to develop and
validate the SCQ in populations of general surgical
patients in hospital settings [17]. In addition, a German
version of the SCQ, the SCQ-D has recently been deve-
loped [21]. The comorbidity measured by the SCQ-D
proved to be a valid predictor of the hospitalization and
the treatment outcome [21].
There are several limitations of this study. First, the
majority of these post discharge data came from a sam-
ple of hospitalized patients with ACS from specific com-
munity hospitals in the Midwest. Second, the use of
hospital medical records may have limited our ability to
capture all the patients’ documented conditions as this is
affected by the quality of documentation. Wording dif-
ferences between self-report source (i.e. before your
hospitalization) and medical record source (designed to
capture both current and past conditions) items may
account for some of our observed differences.Conclusions
Our results show that the self-report SCQ index is a
generally an equivalent predictor of quality of life health
outcomes when compared to a CCI score generated
from medical records data with both predicting physical
functioning similarly. This suggests that patient self-
reported comorbidity data can be used for predicting
functional capacity and quality of life health outcomes
and may serve as a reliable measure for risk adjustment.
Since self-report comorbidity data are often more com-
plete than CCI scores based on medical records and can
easily be collected from patients in a short survey, they
may provide a more cost-effective alternative method for
risk adjustment in clinical research, health policy and
organizational improvement analyses.
Our results are important in the context of increased
use of electronic health records (EHR) and increased use
of electronic records data mining. Problem associatedwith use of administrative data for clinical purposes,
including comorbidity measurement are well known. To
the extent that administrative EHR data become a
source of data to support both clinical and evaluative
purposes, they may continue to suffer from problems of
accuracy and completeness.
Patient recall of past comorbid conditions in the
encounter under time pressure may also be incomplete
or inaccurate. In addition, providers frequently use tech-
nical language that patients do not understand when
inquiring about comorbid conditions. However, with the
increased availability of patient portals in EHR systems,
our findings suggest that meaningful portal prompts
using plain language for patients to directly enter histo-
rical or current changes in their comorbid conditions
may enable providers and researchers to improve their
prediction of longer-term patient outcomes for risk
adjustment. Merging the results of such new patient
portal surveys with the reports of illnesses in the EHR in
real time should support improved patient care and
support chronic disease management.
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